Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Meyer, J. H. Articles by Houle, S. Search for Related Content PubMed Citation Articles by Meyer, J. H. Articles by Houle, S. Neurotransmitters Antidepressants PET Related Article

Serotonin Transporter Occupancy of Five Selective Serotonin Reuptake Inhibitors at Different Doses: An [¹¹C]DASB Positron Emission Tomography Study

OBJECTIVE: Minimum therapeutic doses of paroxetine and citalopram produce 80% occupancy for the serotonin (5-HT) transporter (5-HTT). The authors used [¹¹C]DASB positron emission tomography to measure occupancies of three other selective serotonin reuptake inhibitors (SSRIs) at minimum therapeutic doses. The relationship between dose and occupancy was also investigated. METHOD: Striatal 5-HTT binding potential was measured in 77 subjects before and after 4 weeks of medication administration. Binding potential is proportional to the density of receptors not blocked by medication. Subjects received citalopram, fluoxetine, sertraline, paroxetine, or extended-release venlafaxine. Healthy subjects received subtherapeutic doses; subjects with mood and anxiety disorders received therapeutic doses. Percent reduction in 5-HTT binding potential for each medication and dose was calculated. To obtain test-retest data, binding potential was measured before and after 4 weeks in six additional healthy subjects. RESULTS: Substantial occupancy occurred at subtherapeutic doses for all SSRIs. Compared to test-retest data, each drug at the minimum therapeutic dose had a significant effect on striatal 5-HTT binding potential. Mean occupancy at this dose was 76%–85%. At higher plasma SSRI concentrations, 5-HTT occupancy tended to increase above 80%. For each drug, as the dose (or plasma level) increased, occupancy increased nonlinearly, with a plateau for higher doses. CONCLUSIONS: At tolerable doses, SSRIs have increasing occupancy with increasing plasma concentration or dose. Occupancy of 80% across five SSRIs occurs at minimum therapeutic doses. This suggests that 80% 5-HTT blockade is important for therapeutic effect. Occupancy should be measured during development of antidepressant compounds targeting the 5-HTT.

Related Article:

In This Issue
Am J Psychiatry 2004 161: A96. [Full Text] [PDF]

This article has been cited by other articles:

				X. Liu, O. Vilenski, J. Kwan, S. Apparsundaram, and R. Weikert Unbound Brain Concentration Determines Receptor Occupancy: A Correlation of Drug Concentration and Brain Serotonin and Dopamine Reuptake Transporter Occupancy for Eighteen Compounds in Rats Drug Metab. Dispos., July 1, 2009; 37(7): 1548 - 1556. [Abstract] [Full Text] [PDF]

				N. Praschak-Rieder, M. Willeit, A. A. Wilson, S. Houle, and J. H. Meyer Seasonal Variation in Human Brain Serotonin Transporter Binding Arch Gen Psychiatry, September 1, 2008; 65(9): 1072 - 1078. [Abstract] [Full Text] [PDF]

				P. Blier Resiliency of monoaminergic systems: the 80% rule and its relevance to drug development J Psychopharmacol, August 1, 2008; 22(6): 587 - 589. [PDF]

				J. Booij, J. de Jong, K. de Bruin, R. Knol, M. M.L. de Win, and B. L.F. van Eck-Smit Quantification of Striatal Dopamine Transporters with 123I-FP-CIT SPECT Is Influenced by the Selective Serotonin Reuptake Inhibitor Paroxetine: A Double-Blind, Placebo-Controlled, Crossover Study in Healthy Control Subjects J. Nucl. Med., March 1, 2007; 48(3): 359 - 366. [Abstract] [Full Text] [PDF]

				B. W. Dunlop and C. B. Nemeroff The Role of Dopamine in the Pathophysiology of Depression Arch Gen Psychiatry, March 1, 2007; 64(3): 327 - 337. [Full Text] [PDF]

				M. A. Oquendo, R. S. Hastings, Y.-y. Huang, N. Simpson, R. T. Ogden, X.-z. Hu, D. Goldman, V. Arango, R. L. Van Heertum, J. J. Mann, et al. Brain Serotonin Transporter Binding in Depressed Patients With Bipolar Disorder Using Positron Emission Tomography Arch Gen Psychiatry, February 1, 2007; 64(2): 201 - 208. [Abstract] [Full Text] [PDF]

				R. V. Parsey, A. Ojha, R. T. Ogden, K. Erlandsson, D. Kumar, M. Landgrebe, R. Van Heertum, and J. J. Mann Metabolite Considerations in the In Vivo Quantification of Serotonin Transporters Using 11C-DASB and PET in Humans J. Nucl. Med., November 1, 2006; 47(11): 1796 - 1802. [Abstract] [Full Text] [PDF]

				F. E. Lotrich, R. R. Bies, G. S. Smith, and B. G. Pollock Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies J Psychopharmacol, July 1, 2006; 20(4_suppl): 33 - 40. [Abstract] [PDF]

				A. L. Malizia The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology J Psychopharmacol, July 1, 2006; 20(4_suppl): 100 - 107. [Abstract] [PDF]

				J. Lundberg, I. Odano, H. Olsson, C. Halldin, and L. Farde Quantification of 11C-MADAM Binding to the Serotonin Transporter in the Human Brain J. Nucl. Med., September 1, 2005; 46(9): 1505 - 1515. [Abstract] [Full Text] [PDF]

				J. H. Meyer, S. Houle, S. Sagrati, A. Carella, D. F. Hussey, N. Ginovart, V. Goulding, J. Kennedy, and A. A. Wilson Brain Serotonin Transporter Binding Potential Measured With Carbon 11-Labeled DASB Positron Emission Tomography: Effects of Major Depressive Episodes and Severity of Dysfunctional Attitudes Arch Gen Psychiatry, December 1, 2004; 61(12): 1271 - 1279. [Abstract] [Full Text] [PDF]

				Serotonin-Transporter Binding of Antidepressants at Therapeutic Doses Journal Watch Psychiatry, June 9, 2004; 2004(609): 4 - 4. [Full Text]

Get information about faster international access.

Privacy Policy

Copyright © 2004 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us